Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Apryl Quillen"'
Publikováno v:
Neurology and Therapy. 11:373-384
It is important to achieve good persistence and adherence to disease-modifying therapies (DMTs) to achieve the best outcomes in chronic diseases such as multiple sclerosis (MS). The BETACONNECT device is an electronic auto-injector for the DMT interf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c86ffd86633b9494eb33e50a61442ad
https://doi.org/10.1007/s40120-022-00323-1
https://doi.org/10.1007/s40120-022-00323-1
Autor:
Apryl Quillen, Kim McLeod, Shweta Shah, Mark Bensink, Neel Shah, Carrie Dougherty, Fawad Khan, Jessica Ailani, Pooja Desai, Andrew Rubin
Publikováno v:
The Journal for Nurse Practitioners. 17:462-470
Objective This study was conducted to understand the impact of tracking migraine via an app on patient-provider communication and migraine outcomes as well as patient perspectives of the app. Methods Data collected were (1) patient-reported via a sma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4277c35980ad71d5de2e5d4b83a6df74
https://doi.org/10.1016/j.nurpra.2021.01.014
https://doi.org/10.1016/j.nurpra.2021.01.014
Autor:
Kim McLeod, Italo Biaggioni, Byron Padilla, Laurie Orloski, Augustina Ogbonnaya, Steven Kymes, Binglin Yue, Amy Duhig, Clément François, Joan Cannon, Cyndya A. Shibao, Apryl Quillen
Publikováno v:
Movement Disorders Clinical Practice. 6:235-242
Background Droxidopa is approved for adult patients with symptomatic neurogenic orthostatic hypotension (nOH); there is limited information regarding effects on symptoms, outcomes, and quality of life (QOL) beyond two weeks of treatment. Objective Ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7c90a703c4d38e386b645764304648a
https://doi.org/10.1002/mdc3.12726
https://doi.org/10.1002/mdc3.12726